Literature DB >> 12150800

Isoflavonoids from the roots of Erythrina poeppigiana.

Hitoshi Tanaka1, Tomoko Oh-Uchi, Hideo Etoh, Hiroshi Shimizu, Yoichi Tateishi.   

Abstract

Five isoflavonoids, 7,4'-dihydroxy-2'-methoxy-8-(gamma,gamma-dimethylallyl)isoflav-3-ene, 4'-hydroxy-2'-methoxy-6",6"-dimethylpyran[2",3":7,8]isoflav-3-ene, 5,7,4'-trihydroxy-2'-methoxy-5'-(gamma,gamma-dimethylallyl)isoflavanone, 5,4'-dihydroxy-7,2'-dimethoxy-5'-(gamma,gamma-dimethylallyl)isoflavanone and 3,9-dihydroxy-4-(gamma,gamma-dimethylallyl)pterocarpene as well as six known compounds were isolated from the roots of Erythrina poeppigiana. Their structures were established on the basis of spectroscopic evidence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150800     DOI: 10.1016/s0031-9422(02)00164-4

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  4 in total

1.  Secondary metabolites that could contribute to the monodominance of Erythrina fusca in the Brazilian Pantanal.

Authors:  Darlene Gris; Amanda Galdi Boaretto; Maria Rita Marques; Geraldo Alves Damasceno-Junior; Carlos Alexandre Carollo
Journal:  Ecotoxicology       Date:  2019-11-14       Impact factor: 2.823

2.  Potent apoptosis-inducing activity of erypoegin K, an isoflavone isolated from Erythrina poeppigiana, against human leukemia HL-60 cells.

Authors:  Kiyomi Hikita; Natsuki Hattori; Aya Takeda; Yuko Yamakage; Rina Shibata; Saori Yamada; Kuniki Kato; Tomiyasu Murata; Hitoshi Tanaka; Norio Kaneda
Journal:  J Nat Med       Date:  2017-11-18       Impact factor: 2.343

3.  Gold(I)-catalyzed hydroarylation reaction of aryl (3-iodoprop-2-yn-1-yl) ethers: synthesis of 3-iodo-2H-chromene derivatives.

Authors:  Pablo Morán-Poladura; Eduardo Rubio; José M González
Journal:  Beilstein J Org Chem       Date:  2013-10-16       Impact factor: 2.883

4.  Flavones from Erythrina falcata are modulators of fear memory.

Authors:  Daniela Rodrigues de Oliveira; Cláudia R Zamberlam; Renan Barreta Gaiardo; Gizelda Maia Rêgo; Janete M Cerutti; Alberto J Cavalheiro; Suzete M Cerutti
Journal:  BMC Complement Altern Med       Date:  2014-08-05       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.